完全切除pN2非小细胞肺癌的复发模式:术后放疗是否应重新考虑?
该研究回顾性分析了2005至2016年日本国家癌症中心医院337例完全切除的cN0-1、pN2非小细胞肺癌患者,比较单纯观察与辅助化疗患者的复发模式。结果显示区域淋巴结复发见于超过30%的患者,约20%的患者复发位于系统性淋巴结清扫区域内,单纯观察与辅助化疗的复发模式差异无统计学意义(P=0.145)。作者提出术后放疗或可作为这些患者的附加治疗策略。
要点
- 完全切除pN2 NSCLC患者中区域淋巴结复发率超过30%。
- 约20%患者复发位于系统性淋巴结清扫区域内。
- 单纯观察与辅助化疗的复发模式差异无统计学意义(P=0.145)。
核心结论
- 完全切除pN2非小细胞肺癌患者中区域淋巴结复发率超过30%,其中约20%位于系统性淋巴结清扫区域内。
- 单纯观察与辅助化疗患者的复发模式差异无统计学意义(P=0.145),术后放疗或可考虑作为附加治疗策略。
研究设计与样本
- 回顾性研究纳入2005至2016年日本国家癌症中心医院337例完全切除的cN0-1、pN2非小细胞肺癌患者。
- 比较单纯观察与辅助化疗患者的复发模式,并分析区域淋巴结复发的模式和部位。
主要发现
- 单纯观察与辅助化疗患者的复发模式差异无统计学意义(P=0.145)。
- 68例(20.2%)患者出现系统性淋巴结清扫区域内的淋巴结复发。
关键数值与推荐
- 区域淋巴结复发见于超过30%的完全切除pN2非小细胞肺癌患者。
- 约20%的患者复发位于系统性淋巴结清扫区域内。
- 单纯观察与辅助化疗的复发模式差异P=0.145。
临床怎么用
- 对完全切除pN2非小细胞肺癌患者应关注区域淋巴结复发风险,尤其是系统性淋巴结清扫区域内复发。
- 术后放疗可能作为此类患者的附加治疗策略,需进一步评估。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The prognosis of patients with mediastinal lymph node (LN) metastasis (pN2 stage III disease) is still unsatisfactory. Both systemic and local recurrence should be prevented after curative surgery. The aim of this study was to explore the pattern of recurrence in patients with completely resected pN2 non-small-cell lung cancer (NSCLC) in the era of adjuvant chemotherapy. METHODS: We investigated 337 patients with completely resected cN0-1 and pN2 NSCLC from 2005 to 2016 at National Cancer Center Hospital, Japan. The patterns of recurrence were compared between patients who were managed by observation alone and those with adjuvant chemotherapy. In patients with regional LN recurrence, the pattern and site of recurrence were also explored. RESULTS: There were 195 (58.5%) men and 142 (41.5%) women with a mean age of 63.2 years. Fifty-five (16.3%) patients developed only regional LN recurrence, 116 (32.6%) patients developed only distant recurrence and 65 (19.3%) patients developed both regional LN recurrence and distant recurrence. The difference in the pattern of recurrence between patients with observation alone and those with adjuvant chemotherapy was not statistically significant (P = 0.145). As for the pattern of regional LN recurrence, 68 (20.2%) patients had LN recurrence inside the systematic nodal dissection area. CONCLUSIONS: Regional LN recurrence was observed in >30% of patients with completely resected pN2 NSCLC. About 20% of patients had recurrence inside the systematic nodal dissection area. Postoperative radiotherapy might be considered as an additional treatment strategy for these patients.
引用
- Nakagawa K, Yoshida Y, Yotsukura M, et al. Pattern of recurrence of pN2 non-small-cell lung cancer: should postoperative radiotherapy be reconsidered? Eur J Cardiothorac Surg. 2021. PMID: 32728713. doi:10.1093/ejcts/ezaa267
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。